中医科指南

订阅

MedSci主页 / 所有栏目 / 中医科指南

白癜风诊疗共识(2014版)

2014-01-01 中国中西医结合学会皮肤性病专业委员会 中华皮肤科杂志.2014,47(1):69-71.

白癜风

本指南以中国中西医结合学会皮肤性病专业委员会色素病学组制订的白癜风治疗共识(2009版)为基础，经色素病学组、中华医学会皮肤科分会白癜风研究中心部分专家及国内相关专家讨论制定。对白癜风的治疗方法进行了详细的叙述。

中文标题：

白癜风诊疗共识(2014版)

发布机构：

中国中西医结合学会皮肤性病专业委员会

发布日期：

2014-01-01

简要介绍：

本指南以中国中西医结合学会皮肤性病专业委员会色素病学组制订的白癜风治疗共识(2009版)为基础，经色素病学组、中华医学会皮肤科分会白癜风研究中心部分专家及国内相关专家讨论制定。对白癜风的治疗方法进行了详细的叙述。

相关资料下载：
[AttachmentFileName(sort=100, fileName=白癜风诊疗共识(2014版))] GetToolGuiderByIdResponse(projectId=1, id=11d551c0010389e9, title=白癜风诊疗共识(2014版), enTitle=, guiderFrom=中华皮肤科杂志.2014,47(1):69-71., authorId=null, author=, summary=本指南以中国中西医结合学会皮肤性病专业委员会色素病学组制订的白癜风治疗共识(2009版)为基础，经色素病学组、中华医学会皮肤科分会白癜风研究中心部分专家及国内相关专家讨论制定。对白癜风的治疗方法进行了详细的叙述。, cover=, journalId=null, articlesId=null, associationId=175, associationName=中国中西医结合学会皮肤性病专业委员会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jan 01 08:00:00 CST 2014, originalUrl=http://guide.medlive.cn/guideline/5464, linkOutUrl=, content=本指南以中国中西医结合学会皮肤性病专业委员会色素病学组制订的白癜风治疗共识(2009版)为基础，经色素病学组、中华医学会皮肤科分会白癜风研究中心部分专家及国内相关专家讨论制定。对白癜风的治疗方法进行了详细的叙述。, tagList=[TagDto(tagId=14834, tagName=白癜风)], categoryList=[CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3009, appHits=260, showAppHits=0, pcHits=1767, showPcHits=1358, likes=253, shares=5, comments=6, approvalStatus=1, publishedTime=Wed Jan 01 00:00:00 CST 2014, publishedTimeString=2014-01-01, pcVisible=1, appVisible=1, editorId=null, editor=milly, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=null, createdTime=Wed Jan 01 00:00:00 CST 2014, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 12:55:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=白癜风诊疗共识(2014版))])
白癜风诊疗共识(2014版)
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=952044, encodeId=4db9952044ff, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:26 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952043, encodeId=9d4a95204336, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:24 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952042, encodeId=ed2f9520422c, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:22 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952041, encodeId=05be952041c7, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:20 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903667, encodeId=90a890366e0c, content=有最新的2018版了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bab5440056, createdName=ms8000001658197700, createdTime=Mon Nov 30 21:54:32 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-03-29 黎庶

    刷点分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=952044, encodeId=4db9952044ff, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:26 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952043, encodeId=9d4a95204336, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:24 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952042, encodeId=ed2f9520422c, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:22 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952041, encodeId=05be952041c7, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:20 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903667, encodeId=90a890366e0c, content=有最新的2018版了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bab5440056, createdName=ms8000001658197700, createdTime=Mon Nov 30 21:54:32 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-03-29 黎庶

    刷点分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=952044, encodeId=4db9952044ff, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:26 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952043, encodeId=9d4a95204336, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:24 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952042, encodeId=ed2f9520422c, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:22 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952041, encodeId=05be952041c7, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:20 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903667, encodeId=90a890366e0c, content=有最新的2018版了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bab5440056, createdName=ms8000001658197700, createdTime=Mon Nov 30 21:54:32 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-03-29 黎庶

    刷点分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=952044, encodeId=4db9952044ff, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:26 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952043, encodeId=9d4a95204336, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:24 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952042, encodeId=ed2f9520422c, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:22 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952041, encodeId=05be952041c7, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:20 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903667, encodeId=90a890366e0c, content=有最新的2018版了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bab5440056, createdName=ms8000001658197700, createdTime=Mon Nov 30 21:54:32 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-03-29 黎庶

    刷点分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=952044, encodeId=4db9952044ff, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:26 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952043, encodeId=9d4a95204336, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:24 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952042, encodeId=ed2f9520422c, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:22 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952041, encodeId=05be952041c7, content=刷点分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Mon Mar 29 14:16:20 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903667, encodeId=90a890366e0c, content=有最新的2018版了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bab5440056, createdName=ms8000001658197700, createdTime=Mon Nov 30 21:54:32 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2020-11-30 ms8000001658197700

    有最新的2018版了

    0